Health status of White Americans

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED MARCH 31, 2022 AND APPOINTMENT OF HAARIS UDDIN AS CHIEF FINANCIAL OFFICER

Retrieved on: 
Tuesday, May 31, 2022

ZYPITAMAG contributed $1.0 million of revenue for the quarter ended March 31, 2022 compared to $161,000 for the quarter ended March 31, 2021.

Key Points: 
  • ZYPITAMAG contributed $1.0 million of revenue for the quarter ended March 31, 2022 compared to $161,000 for the quarter ended March 31, 2021.
  • The Marley Drug business contributed $1.9 million of revenue during the quarter ended March 31, 2022 compared to $2.1 million for the quarter ended March 31, 2021.
  • Adjusted EBITDA for the three months ended March 31, 2022 was $1.2 million compared to $31,000 for the three months ended March 31, 2021.
  • Cash flows used in operating activities for the quarter ended March 31, 2022 totaled $736,000 compared to $224,000 from operating activities for the quarter ended March 31, 2021.

Insurtech Pendella Adds PEO AdvanStaff HR As Partner

Retrieved on: 
Thursday, May 26, 2022

Through Pendella's AI-powered, white-labeled technology, AdvanStaff HR clients will be able to expand their employee offerings to include individual life insurance.

Key Points: 
  • Through Pendella's AI-powered, white-labeled technology, AdvanStaff HR clients will be able to expand their employee offerings to include individual life insurance.
  • Employees of AdvanStaff HR clients can now choose from a variety of affordable individual life and disability insurance options available from top-rated national insurance providers.
  • AdvanStaff HR has helped companies run their businesses efficiently and successfully for nearly 30 years.
  • We are excited to partner with AdvanStaff HR and bring the important financial protection that life insurance offers to the thousands of employees they support, said Bob Gaydos, Pendella CEO and founder.

Animal health giant introduces vaccine in Middle East and North Africa to control foot-and-mouth disease and improve livestock productivity

Retrieved on: 
Thursday, May 19, 2022

The seminar "Foot and Mouth Disease status in the Middle East" was attended by authorities who are responsible of protecting the health status of a region which has an estimated 1 billion heads of livestock, between sheep, goats, cattle and camelids.

Key Points: 
  • The seminar "Foot and Mouth Disease status in the Middle East" was attended by authorities who are responsible of protecting the health status of a region which has an estimated 1 billion heads of livestock, between sheep, goats, cattle and camelids.
  • "Biognesis Bags vaccine will be key to protecting the region's animal health status and productivity.
  • Dr. Esteban Turic, CEO at Biogenesis Bag, also emphasized about the region's main animal health issues and the company's approach towards working together for its control.
  • Biognesis Bag is an international biotechnology company with more than 80 years of experience, specialized in the development, production, and commercialization of products for animal health and productivity.

Pendella to Bring Individual Life Insurance Offerings to SpiritHR Technology Platform

Retrieved on: 
Tuesday, May 17, 2022

FORT MYERS, Fla., May 17, 2022 (GLOBE NEWSWIRE) -- Pendella Technologies, a fast-growing technology company on a mission to take the bias out of life insurance, and HR services provider SpiritHR will partner to expand the availability of life insurance to employees nationwide.

Key Points: 
  • FORT MYERS, Fla., May 17, 2022 (GLOBE NEWSWIRE) -- Pendella Technologies, a fast-growing technology company on a mission to take the bias out of life insurance, and HR services provider SpiritHR will partner to expand the availability of life insurance to employees nationwide.
  • The partnership enables SpiritHR to integrate Pendellas white-labeled technology platform into its employee portal, giving individuals access to a variety of comprehensive and affordable life insurance policies.
  • The SpiritHR team serves as a business partner to its clients, combining its easy-to-use cloud-based HRIS technology platform with personal service from a dedicated team of professionals.
  • Pendella is a technology company that exists to make the financial protection of individual life and disability insurance available to all people, regardless of age, health status, or income level.

Humana’s CenterWell Senior Primary Care and Welsh, Carson, Anderson & Stowe Announce Second Joint Venture to Develop and Operate Value-Based Primary Care Clinics for Medicare Patients

Retrieved on: 
Monday, May 16, 2022

Humana Inc.s (NYSE: HUM) CenterWell Senior Primary Care and Welsh, Carson, Anderson & Stowe (WCAS) have established a second joint venture (JV) to further expand access to value-based primary care clinics for Medicare patients.

Key Points: 
  • Humana Inc.s (NYSE: HUM) CenterWell Senior Primary Care and Welsh, Carson, Anderson & Stowe (WCAS) have established a second joint venture (JV) to further expand access to value-based primary care clinics for Medicare patients.
  • All de novo clinics developed through the Humana-WCAS joint ventures will be managed and operated under Humanas CenterWell Senior Primary Care brand.
  • Physicians and patients alike are coming to recognize the many advantages of our unique, senior-focused primary care model, said Rene Buckingham, President of Humanas Primary Care Organization which operates both CenterWell Senior Primary Care and Conviva Care Centers.
  • Under the new JV agreement, CenterWell Senior Primary Care will receive a management fee, including performance-based incentives, for the management of all joint venture clinics.

Trellis Rx Partner Parkview Health Earns Prestigious Award for Specialty Pharmacy Patient Satisfaction

Retrieved on: 
Tuesday, May 10, 2022

Managed Market Insight and Technology (MMIT) has announced that Trellis Rx partner Parkview Health has received the prestigious 2022 Specialty Pharmacy Patient Choice Award for the Hospital & Health System category .

Key Points: 
  • Managed Market Insight and Technology (MMIT) has announced that Trellis Rx partner Parkview Health has received the prestigious 2022 Specialty Pharmacy Patient Choice Award for the Hospital & Health System category .
  • The Specialty Pharmacy Patient Choice Award is given to the organization that delivers the best patient experience in each category as measured by the average Net Promoter Score (NPS) in the Zitter Insights Specialty Pharmacy Patient Satisfaction Survey.
  • On behalf of all our colleagues at Trellis Rx, I want to congratulate Parkview Health and Summa Health on receiving this important recognition from MMIT, said Brandon Newman, Chief Operating Officer for Trellis Rx.
  • Parkview Health launched the Parkview Specialty Pharmacy in August 2019 in partnership with Trellis Rx.

Welcome to Your Workplace: New Features From Envoy Add a Personalized App Experience for Hybrid Employees

Retrieved on: 
Thursday, April 28, 2022

Jamf, a software company whose purpose is to empower people by simplifying work, has used Envoy since 2019.

Key Points: 
  • Jamf, a software company whose purpose is to empower people by simplifying work, has used Envoy since 2019.
  • With Envoy, our employees manage their schedules from one app on their phones which makes their experience that much better.
  • And better yet, employees can tailor their experience with personalized touches like:
    Favorites - Prioritize teammates you work with often by marking them as favorites in the Envoy app.
  • Envoy is transforming modern workplaces for hybrid work and safely bringing people together so they can connect, collaborate, and thrive.

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2021

Retrieved on: 
Thursday, April 28, 2022

ZYPITAMAG contributed $3.1 million of revenue for the year ended December 31, 2021 compared to $453,000 for the year ended December 31, 2020.

Key Points: 
  • ZYPITAMAG contributed $3.1 million of revenue for the year ended December 31, 2021 compared to $453,000 for the year ended December 31, 2020.
  • The Marley Drug business, acquired on December 17, 2020, contributed $6.9 million of revenue for the year ended December 31, 2021.
  • Adjusted EBITDA for the three months ended December 31, 2021 was $1.6 million compared to negative $1.4 million for the three months ended December 31, 2020.
  • Adjusted EBITDA for the year ended December 31, 2021 was $2.1 million compared to negative $3.9 million for the year ended December 31, 2020.

Oceana Canada finds capelin to be critically depleted and overfished, calls for a fishery closure to help rebuild the population

Retrieved on: 
Wednesday, April 27, 2022

Heavy fishing pressure on this collapsed population causes harm to the ecosystem and contributes to a poor outlook for the future of this fishery.

Key Points: 
  • Heavy fishing pressure on this collapsed population causes harm to the ecosystem and contributes to a poor outlook for the future of this fishery.
  • Oceana Canada is calling on DFO to close the fishery until it can demonstrate the population is growing out of the critical zone.
  • Future harvest levels, once the population recovers, must take into consideration the essential contributions capelin play as prey for other species, including critically depleted northern cod.
  • The 2021 quota was still higher than this critically depleted population can withstand, preventing population recovery.

Humana Reports First Quarter 2022 Financial Results; Raises Full Year 2022 Adjusted EPS Financial Guidance

Retrieved on: 
Wednesday, April 27, 2022

FY 2022 GAAP EPS guidance excludes the impact of future value changes of these put/call options as the future value changes cannot be estimated.

Key Points: 
  • FY 2022 GAAP EPS guidance excludes the impact of future value changes of these put/call options as the future value changes cannot be estimated.
  • (e) FY 2021 Adjusted results exclude the following:
    Amortization expense for identifiable intangibles of approximately $0.39 per diluted common share.
  • This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995.
  • More information regarding Humana is available to investors via the Investor Relations page of the companys website at humana.com, including copies of: